Labetalol Ameliorates Experimental Colitis in Rat Possibly Through its Effect on Proinflammatory Mediators and Oxidative Stress
Clinical Laboratory · 2024
DOI: 10.7754/clin.lab.2023.230659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2024. Verfasst von Jaffar O Dawood und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Labetalol, Colitis. Die Arbeit wurde bisher 22-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND: Members of beta blockers drugs possess significant antioxidant activities. The current research is to assess the effect of the labetalol on acetic acid (AA-induced) colitis in rat model. METHODS: Forty adult Wistar rats were separated into 4 groups, including the negative control group, AA group, AA + sulfasalazine (100 mg/kg/day) group, and AA + labetalol (300 mg/kg/day) group. Colitis was induced in rats by the interrectal installation of 2 mL of 4% (v/v) AA. Sulfasalazine and labetalol were administered orally for 7 days after 2 hours of induction. The following parameters were measured: disease activity index (DAI), histopa-thological changes and colon tissue homogenate concentrations of proinflammatory mediators IL-1β, adhesion molecules ICAM-1, and oxidative stress marker myeloperoxidase (MPO). RESULTS: The treatment with labetalol significantly reduced DAI and histopathological changes induced by AA. Also, labetalol markedly decreased the concentrations of IL-1β, ICAM-1, and MPO in colonic tissue that were increased by AA. The effects of labetalol were significantly lower than that produced by sulfasalazine as standard drug. CONCLUSIONS: Labetalol exerts ameliorative effects on disease activity and histopathological features of AA-induced colitis in rats possibly through antioxidant effects and inhibition of inflammatory mediators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Dawood, J. O., & Abu-Raghif, A. (2024). Labetalol Ameliorates Experimental Colitis in Rat Possibly Through its Effect on Proinflammatory Mediators and Oxidative Stress. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2023.230659
Vancouver
Dawood JO, Abu-Raghif A. Labetalol Ameliorates Experimental Colitis in Rat Possibly Through its Effect on Proinflammatory Mediators and Oxidative Stress. Clinical Laboratory. 2024. doi:10.7754/clin.lab.2023.230659
BibTeX
@article{Dawood2024,
author = {Dawood, Jaffar O and Abu-Raghif, Ahmed},
title = {Labetalol Ameliorates Experimental Colitis in Rat Possibly Through its Effect on Proinflammatory Mediators and Oxidative Stress},
journal = {Clinical Laboratory},
year = {2024},
doi = {10.7754/clin.lab.2023.230659}
}
EUVIMED